Similar results were obtained using PC9 cells as T-cell targets (supplementary Figs. S5G-J), as well as in A549 cells with TAP2 gene elimination, in which the cancer cell survival increase was suppressed by the re-introduction of TAP2 (Fig. 3M-P). The gene discussed is TAP2; the disease is cancer.